Literature DB >> 11081535

HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts.

E F Bowen, P S Rice, N T Cooke, R J Whitfield, C F Rayner.   

Abstract

Having witnessed a large increase in Mycobacterium tuberculosis notifications in south London, we wanted to ascertain the prevalence of HIV and tuberculosis co-infection in our patients. All patients with tuberculosis and their contacts were anonymously tested for HIV in blood and saliva, respectively. 11.4% of patients (from various demographic groups) with tuberculosis who attend chest clinics in south London are HIV positive. In addition, 5% of individuals seen in the tuberculosis contact screening clinics and 4% new entrants are HIV positive. All patients with Mycobacterium tuberculosis, irrespective of background, should be urged to have an HIV test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081535     DOI: 10.1016/S0140-6736(00)02876-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Tuberculosis in primary care.

Authors:  Surinder Singh; Sara Madge; Marc Lipman
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

2.  Current medical treatment for tuberculosis. Resources used for screening could be spent more usefully elsewhere.

Authors:  Ruth J Whitfield; Rosemary Khan; Anne Smith; Charlotte F J Rayner
Journal:  BMJ       Date:  2003-03-08

Review 3.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

4.  Current difficulties in the diagnosis and management of spinal tuberculosis.

Authors:  L Cormican; R Hammal; J Messenger; H J Milburn
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

5.  HIV testing in TB clinics: a problem in practice?

Authors:  S Dart; D Alder; M Mamdani; A Solamalai; A Evans; N Johnson; I Cropley; M Lipman
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

6.  Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless.

Authors:  G H Bothamley; J P Rowan; C J Griffiths; M Beeks; M McDonald; E Beasley; C van den Bosch; G Feder
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

7.  Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States.

Authors:  Anna K Person; Neela D Goswami; Deborah J Bissette; Debra S Turner; Ann V Baker; L Beth Gadkowski; Susanna Naggie; Kirby Erlandson; Luke Chen; Tahaniyat Lalani; Gary M Cox; Jason E Stout
Journal:  AIDS Patient Care STDS       Date:  2010-09       Impact factor: 5.078

8.  Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers.

Authors:  J A H Droste; C P W G M Verweij-van Wissen; B P Kearney; R Buffels; P J Vanhorssen; Y A Hekster; D M Burger
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.

Authors:  C J L la Porte; E P H Colbers; R Bertz; D S Voncken; K Wikstrom; M J Boeree; P P Koopmans; Y A Hekster; D M Burger
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission.

Authors:  H Maguire; J W Dale; T D McHugh; P D Butcher; S H Gillespie; A Costetsos; H Al-Ghusein; R Holland; A Dickens; L Marston; P Wilson; R Pitman; D Strachan; F A Drobniewski; D K Banerjee
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.